Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

BACKGROUND: Chronic liver injury (CLI) is now a worldwide disease. However, there is no effective treatment. Pyroptosis plays an essential role in CLI. Dihydromyricetin (DHM) resists oxidation and protects the liver. We hypothesize that the beneficial effect of DHM on CLI is related to its effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Quan-Cheng, Fan, Jing, Deng, Xin-Wei, Liu, Huai-Cun, Ding, Hui-Ru, Fang, Xuan, Wang, Jian-Wei, Chen, Chun-Hua, Zhang, Wei-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656208/
https://www.ncbi.nlm.nih.gov/pubmed/33244197
http://dx.doi.org/10.3748/wjg.v26.i41.6346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656208/
https://www.ncbi.nlm.nih.gov/pubmed/33244197
http://dx.doi.org/10.3748/wjg.v26.i41.6346

Ejemplares similares